Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: A multicenter double-blind placebo-controlled fixed-dose study

Dose Study ◽

Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study

International Journal of Impotence Research ◽

10.1038/ijir.2013.38 ◽

2013 ◽

Vol 26 (2) ◽

pp. 76-80 ◽

Cited By ~ 23

Author(s):

Y S Shim ◽

C-U Pae ◽

K J Cho ◽

S W Kim ◽

J C Kim ◽

...

Keyword(s):

Erectile Dysfunction ◽

Erectile Function ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Treatment ◽

Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial

Asian Journal of Andrology ◽

10.1111/j.1745-7262.2008.00422.x ◽

2008 ◽

Vol 10 (5) ◽

pp. 791-798 ◽

Cited By ~ 16

Author(s):

Jae-Seung Paick ◽

Hyung-Ki Choi ◽

Sae-Chul Kim ◽

Tai-Young Ahn ◽

Je-Jong Kim ◽

...

Keyword(s):

Clinical Trial ◽

Erectile Dysfunction ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

The World Journal of Biological Psychiatry ◽

10.3109/15622975.2011.600333 ◽

2011 ◽

Vol 14 (4) ◽

pp. 268-281 ◽

Cited By ~ 9

Author(s):

Miguel Casas ◽

Michael Rösler ◽

J. J. Sandra Kooij ◽

Ylva Ginsberg ◽

Josep Antoni Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Fixed Dose ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Safety and Efficacy of Epelsiban in the Treatment of Men with Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study

Yearbook of Urology ◽

10.1016/j.yuro.2014.01.016 ◽

2014 ◽

Vol 2014 ◽

pp. 122-123

Author(s):

A.W. Shindel

Keyword(s):

Premature Ejaculation ◽

Fixed Dose ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

Urology ◽

10.1016/s0090-4295(03)00115-8 ◽

2003 ◽

Vol 61 (4) ◽

pp. 8-14 ◽

Cited By ~ 95

Author(s):

Wayne J.G. Hellstrom ◽

Marc Gittelman ◽

Gary Karlin ◽

Thomas Segerson ◽

Marc Thibonnier ◽

...

Keyword(s):

Erectile Dysfunction ◽

Pivotal Trial ◽

Double Blind ◽

Sustained Efficacy ◽

Effects of a phosphodiesterase type 5 inhibitor (SILDENAFIL) evaluated by 24-hour blood pressure monitoring and exercise capacity in heart transplanted patients. A double-blind, placebo-controlled, cross-over, randomized study. Preliminary results

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2004.11.246 ◽

2005 ◽

Vol 24 (2) ◽

pp. S115

Author(s):

G.V. Guimaraes ◽

V.M. d’Avila ◽

P.V. Pires ◽

F.D. Cruz ◽

N.A. Stolf ◽

...

Keyword(s):

Blood Pressure ◽

Exercise Capacity ◽

Blood Pressure Monitoring ◽

Randomized Study ◽

Pressure Monitoring ◽

Double Blind ◽

Double Blind Placebo ◽

Preliminary Results ◽

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Cited By ~ 233

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction

Urology ◽

10.1016/s0090-4295(00)00688-9 ◽

2000 ◽

Vol 56 (4) ◽

pp. 635-640 ◽

Cited By ~ 41

Author(s):

Hui Meng Tan ◽

Clarence Lei Chang Moh ◽

Jesus Benjamin Mendoza ◽

Telesforo Gana ◽

German Jose Albano ◽

...

Keyword(s):

Erectile Dysfunction ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study ◽

Flexible Dose

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder

International Clinical Psychopharmacology ◽

10.1097/00004850-199506000-00001 ◽

1995 ◽

Vol 10 (2) ◽

pp. 57-66 ◽

Cited By ~ 84

Author(s):

J. H. Greist ◽

J. W. Jefferson ◽

K. A. Kobak ◽

G. Chouinard ◽

E. DuBoff ◽

...

Keyword(s):

Obsessive Compulsive Disorder ◽

Fixed Dose ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Compulsive Disorder ◽

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study

Depression and Anxiety ◽

10.1002/da.20014 ◽

2004 ◽

Vol 19 (4) ◽

pp. 241-248 ◽

Cited By ~ 101

Author(s):

Malcolm Lader ◽

Karina Stender ◽

Vera Bürger ◽

Rico Nil

Keyword(s):

Anxiety Disorder ◽

Social Anxiety ◽

Social Anxiety Disorder ◽

Fixed Dose ◽

Double Blind ◽

Double Blind Placebo ◽